Pulse Biosciences Inc Net debt/EBITDA
Что обозначает Net debt/EBITDA в Pulse Biosciences Inc?
Net debt/EBITDA Pulse Biosciences Inc является 3.11
Какое определение для Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA компаний в Health Care сектор на NASDAQ по сравнению с Pulse Biosciences Inc
Что делает Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Компании с net debt/ebitda похож на Pulse Biosciences Inc
- Active PLC имеет Net debt/EBITDA из 3.09
- CarParts.com Inc имеет Net debt/EBITDA из 3.10
- Civeo Corp имеет Net debt/EBITDA из 3.10
- Marin Software Inc имеет Net debt/EBITDA из 3.10
- Tech Data имеет Net debt/EBITDA из 3.10
- TAKKT AG имеет Net debt/EBITDA из 3.11
- Pulse Biosciences Inc имеет Net debt/EBITDA из 3.11
- Koenig & Bauer AG имеет Net debt/EBITDA из 3.11
- Public Joint Stock Mining and Metallurgical Norilsk Nickel имеет Net debt/EBITDA из 3.11
- China Hanking имеет Net debt/EBITDA из 3.11
- Ajinomoto Co имеет Net debt/EBITDA из 3.11
- H&R GmbH & Co. KGaA имеет Net debt/EBITDA из 3.11
- H&R GmbH & Co. KGaA имеет Net debt/EBITDA из 3.11